Skip to content

Nurix Therapeutics, Inc. NRIX Prepaid & Other Current

Prepaid & Other Current at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$26.5M+48.9%
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$6.72M+40.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$10.12M-20.3%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$22.56M+9.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.53M-61.2%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$48.87M+307%

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s prepaid & other current?
Nurix Therapeutics, Inc. (NRIX) reported prepaid & other current of $13.66M in Q4 2025.
How has Nurix Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Nurix Therapeutics, Inc.'s prepaid & other current decreased by 2.6% year-over-year, from $14.02M to $13.66M.
What is the long-term trend for Nurix Therapeutics, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s prepaid & other current has grown at a 17.0% compound annual growth rate (CAGR), from $26.83M to $50.22M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.